By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Actelion Pharmaceuticals US, Inc. 

5000 Shoreline Court
Suite 200
South San Francisco  California  94080  U.S.A.
Phone: 650-624-6900 Fax: 650-589-1501


SEARCH JOBS




Collaborations

Merck & Co., Inc.  Cardiovascular





Company News
Actelion Pharmaceuticals US, Inc. (ATLN.VX) Nabs Ceptaris Therapeutics, Inc. in $250 Million Buyout Deal 8/1/2013 7:14:58 AM
Actelion Ltd. (ALIOF.PK) Shareholders Reject Executive Pay Plan 4/19/2013 8:18:19 AM
Federal Trade Commission Slams Actelion Pharmaceuticals US, Inc. (ATLN.VX) for Withholding Samples 3/13/2013 7:31:02 AM
Auxilium Pharmaceuticals (AUXL) and Actelion Pharmaceuticals US, Inc. (ATLN.VX) Announce Approval of XIAFLEX┬« In Canada 7/9/2012 7:31:48 AM
FDA Approves Actelion Pharmaceuticals US, Inc. (ATLN.VX)'s SNDA for Second Generation VELETRI for Injection 6/29/2012 7:06:20 AM
Auxilium Pharmaceuticals (AUXL) and Actelion Pharmaceuticals US, Inc. (ATLN.VX) Enter a Collaboration Agreement for XIAFLEX┬« in Canada, Australia, Brazil and Mexico for Up to $68.5 Million 2/23/2012 7:39:59 AM
Actelion Pharmaceuticals US, Inc. (ATLN.VX) Floods FDA With Patient Death Reports 10/6/2011 7:50:51 AM
Actelion Pharmaceuticals US, Inc. (ATLN.VX) Release: Pulmonary Hypertension Association Names Dr. Ronald Oudiz Recipient of 2011 Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care 5/18/2011 9:03:06 AM
Updated U.S. Product Labeling for Actelion Ltd. (ALIOF.PK)'s Veletri (Epoprostenol for Injection) Allows Patients to Prepare This Medication Up to a Week in Advance of Use for Pulmonary Arterial Hypertension 10/5/2010 11:43:22 AM
Actelion Pharmaceuticals US, Inc. (ATLN.VX) Pays Eur 10 Million for Option to Buy Trophos for up to Eur 195 Million 7/20/2010 12:21:56 PM
123
//-->